Annual Retained Earnings
-$391.07 M
+$22.81 M+5.51%
December 31, 2023
Summary
- As of February 8, 2025, SPRO annual retained earnings is -$391.07 million, with the most recent change of +$22.81 million (+5.51%) on December 31, 2023.
- During the last 3 years, SPRO annual retained earnings has fallen by -$113.36 million (-40.82%).
- SPRO annual retained earnings is now -2060.62% below its all-time high of -$18.10 million, reached on December 31, 2015.
Performance
SPRO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$438.75 M
-$17.15 M-4.07%
September 30, 2024
Summary
- As of February 8, 2025, SPRO quarterly retained earnings is -$438.75 million, with the most recent change of -$17.15 million (-4.07%) on September 30, 2024.
- Over the past year, SPRO quarterly retained earnings has dropped by -$47.68 million (-12.19%).
- SPRO quarterly retained earnings is now -865.56% below its all-time high of -$45.44 million, reached on December 31, 2016.
Performance
SPRO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
SPRO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.5% | -12.2% |
| 3 y3 years | -40.8% | -12.2% |
| 5 y5 years | -182.4% | -12.2% |
SPRO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.4% | +5.5% | -19.4% | +0.8% |
| 5 y | 5-year | -96.1% | +5.5% | -120.0% | +0.8% |
| alltime | all time | -2060.6% | +5.5% | -865.6% | +0.8% |
Spero Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$438.75 M(+4.1%) |
| Jun 2024 | - | -$421.60 M(+4.4%) |
| Mar 2024 | - | -$403.74 M(+3.2%) |
| Dec 2023 | -$391.07 M(-5.5%) | -$391.07 M(-11.6%) |
| Sep 2023 | - | -$442.26 M(+0.7%) |
| Jun 2023 | - | -$439.06 M(+2.8%) |
| Mar 2023 | - | -$427.14 M(+3.2%) |
| Dec 2022 | -$413.88 M(+12.6%) | -$413.88 M(-6.1%) |
| Sep 2022 | - | -$440.65 M(+2.7%) |
| Jun 2022 | - | -$428.97 M(+7.2%) |
| Mar 2022 | - | -$400.29 M(+8.9%) |
| Dec 2021 | -$367.46 M(+32.3%) | -$367.46 M(+8.6%) |
| Sep 2021 | - | -$338.22 M(+7.1%) |
| Jun 2021 | - | -$315.70 M(+6.3%) |
| Mar 2021 | - | -$297.13 M(+7.0%) |
| Dec 2020 | -$277.71 M | -$277.71 M(+7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -$259.12 M(+7.9%) |
| Jun 2020 | - | -$240.19 M(+7.9%) |
| Mar 2020 | - | -$222.69 M(+11.7%) |
| Dec 2019 | -$199.43 M(+44.0%) | -$199.43 M(+14.3%) |
| Sep 2019 | - | -$174.44 M(+11.3%) |
| Jun 2019 | - | -$156.72 M(+9.2%) |
| Mar 2019 | - | -$143.57 M(+3.7%) |
| Dec 2018 | -$138.50 M(+43.0%) | -$138.50 M(+8.3%) |
| Sep 2018 | - | -$127.90 M(+8.9%) |
| Jun 2018 | - | -$117.44 M(+9.3%) |
| Mar 2018 | - | -$107.48 M(+11.0%) |
| Dec 2017 | -$96.84 M(+113.1%) | -$96.84 M(+17.8%) |
| Sep 2017 | - | -$82.19 M(+14.2%) |
| Jun 2017 | - | -$71.98 M(+58.4%) |
| Dec 2016 | -$45.44 M(+151.0%) | -$45.44 M |
| Dec 2015 | -$18.10 M | - |
FAQ
- What is Spero Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Spero Therapeutics?
- What is Spero Therapeutics annual retained earnings year-on-year change?
- What is Spero Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Spero Therapeutics?
- What is Spero Therapeutics quarterly retained earnings year-on-year change?
What is Spero Therapeutics annual retained earnings?
The current annual retained earnings of SPRO is -$391.07 M
What is the all time high annual retained earnings for Spero Therapeutics?
Spero Therapeutics all-time high annual retained earnings is -$18.10 M
What is Spero Therapeutics annual retained earnings year-on-year change?
Over the past year, SPRO annual retained earnings has changed by +$22.81 M (+5.51%)
What is Spero Therapeutics quarterly retained earnings?
The current quarterly retained earnings of SPRO is -$438.75 M
What is the all time high quarterly retained earnings for Spero Therapeutics?
Spero Therapeutics all-time high quarterly retained earnings is -$45.44 M
What is Spero Therapeutics quarterly retained earnings year-on-year change?
Over the past year, SPRO quarterly retained earnings has changed by -$47.68 M (-12.19%)